-
Cancer drugs in shortage: 15 supply updates
One cancer drug shortage has ended and at least 14 oncology drugs are in short supply, according to the FDA, the American Society of Health-System Pharmacists and physicians. -
Weight-loss drug market could reach $100B by 2035
The market for drugs like Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy is projected to reach $100 billion by 2035, Fortune reported Sept. 22. -
VCU energizes its pharmacy plan
VCU Health is doubling down on its pharmacy strategy and mail-order medication services, according to Michael Roussos, president of VCU Medical Center. -
Florida hospital treats DMD patient with new, $3.2M gene therapy
For the first time in Florida, physicians administered a recently approved gene therapy for Duchenne muscular dystrophy to a pediatric patient. -
Pediatric cancer drugs in short supply
As the supply of two staple cancer drugs rebounds after months of scarcity, two medications used in pediatric cancer patients have fallen into shortage, NBC News reported Sept. 25. -
Pfizer restarts production at North Carolina plant hit by tornado
Production has resumed at Pfizer's 1.4 million square foot manufacturing plant that was damaged in July by a tornado, the company announced Sept. 25. -
Ulcer drug recalled amid contamination risk
A Florida-based drugmaker is pulling one lot of an ulcer drug because of a possible Bacillus cereus contamination. -
CDC recommends RSV shot for pregnant individuals
All individuals who are between 32 and 36 weeks pregnant should receive the respiratory syncytial virus vaccine this fall, the CDC's Advisory Committee on Immunization Practices recommended Sept. 22 by an 11-1 vote. -
Rite Aid eyes closing hundreds of pharmacies
Rite Aid proposed closing nearly a fourth of its 2,100 pharmacies and declaring bankruptcy, people familiar with the matter told The Wall Street Journal in a Sept. 22 story. -
Hospital changes policies after its pharmacy director sold empty COVID-19 vaccine vials
A Chicago hospital strengthened its product disposal rules in 2021 after its pharmacy director at the time sold empty COVID-19 vaccine vials on Craigslist, CBS News reported Sept. 20. -
Penn Medicine promotes chief pharmacy officer
Philadelphia-based Penn Medicine has appointed Nishaminy Kasbekar, PharmD, as vice president and chief pharmacy officer, according to a Sept. 21 LinkedIn post. -
Florida system invests in medication adherence
Baptist Health South Florida is partnering with EveryDose, a digital health company, to digitize medication adherence processes. -
FDA panel rejects diabetes drug implant for 3rd time
An FDA panel voted 19-0 Sept. 21 to reject ITCA 650, an experimental Type 2 diabetes drug delivery product, after refusing approval twice. -
Kaiser pharmacy workers authorize strike
Kaiser Permanente pharmacy workers in Oregon and Washington plan to strike for three weeks in October, adding to the growing tally of what could be the largest healthcare strike in U.S. history. -
FDA vetoes approving 1st needle-free EpiPen, asks for more data
Before the FDA possibly approves the nation's first needle-free EpiPen product, the agency wants a San Diego-based drugmaker to conduct another study. -
Baptist Health's $40M central fill pharmacy: 5 things to know
Baptist Health, a nine-hospital system based in Louisville, Ky., is constructing a $40 million central fill pharmacy in La Grange, Ky. Here are five things to know about the project: -
Finding Solutions to U.S. Drugs Shortages in 2023 and Beyond: A Manufacturer’s Perspective
As we move closer to the end of this year, it is unfortunate to note that U.S. drug shortages are at an all-time high. Also unfortunate is that this is not a new issue. Drug shortages have been occurring in the United States for far too long. -
ADHD medication errors rose 300% since 2000, report finds
ADHD-related medication errors rose 299 percent between 2000 and 2021, according to new research published in Pediatrics on Sept. 18. -
Humira biosimilars falter in disrupting the market
Numerous Humira biosimilars are on the market after AbbVie's 20-year exclusive on the rheumatoid arthritis biologic, but they aren't fostering much competition, KFF Health News reported Sept. 19. -
FDA raises safety issue in generic organ anti-rejection drug
The FDA reduced its therapeutic equivalence rating in Accord Healthcare's tacrolimus oral capsules because of safety concerns, but the generic's approval remains, the agency said Sept. 19.
Page 2 of 50